Pioneering digital cytometry.
Accelerating biomarker discovery.
iSort™ provides high-
resolution cellular profiling
— at the click of a button.
iSort’s simple workflow is backed by a powerful AI platform based on the most widely used and validated technology in the field.
Our ProductsUnlocking new potential in life sciences research with an AI-powered deconvolution platform.
Founded by Stanford professors, seasoned entrepreneurs, and bioinformatics industry veterans, CiberMed is a biotechnology company that has developed the first commercially available, industrial-grade platform for digital cytometry.
Called iSort™, our robust, best-in-class platform offers an accurate, high throughput, low cost alternative to other methods to determine cell type composition.
For a broad range of applications:
- Tumor Microenvironmental Profiling
- Biomarker Discovery
- Blood Profiling
- Companion Diagnostics
- Normal Tissue Development
Across a diverse range of disease areas and conditions:
- Cancer
- Autoimmune Disease
- Transplantation
- Infertility
Trusted by leading pharmaceutical companies, diagnostic companies, academic researchers, and university medical centers.
A new standard in cellular profiling.
Run a free trial of iSort™ to experience accurate, robust, and simple AI-powered digital cytometry.
Built by a team of seasoned experts.
Brought together by a shared vision and a commitment to scientific excellence, the CiberMed leadership team is a cross-disciplinary group of veterans in their fields, including Stanford professors and physicians, bioinformatics and data science experts, and seasoned biotech entrepreneurs.
Our Team
